Stock screener

KRYS

Conviction 58HealthcareScan · Mon, Aug 10, 2026
KRYS$331.25+1.47%
ResistanceSupportVol 14Insider sell
63 bars
22
Vol MA14 742.91K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Krystal Biotech, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.krystalbio.com ↗
Price331.25
Change+1.47%
Gap+0.00%
Rel volume0.64×
Avg volume650.92K
Avg $ vol217.86M
SMA 20339.74
SMA 50339.72
SMA 200275.95
Price vs 50-2.50%
Price vs 200+20.04%
MA stackmixed
50/200 cross—
Supertrenddown · 371.66
RSI (14)46
MACD hist-2.92
MACD crossbear · 6d
Stoch %K / %D48 / 41
ADX (14)26
+DI / −DI16 / 29
RSI divergence—
MACD divergenceBullish
ATR %+4.73%
ADR %5.03%
52w high378.15
52w low137.46
From 52w high-12.40%
Above 52w low+140.98%
New 52w highNo
SqueezeOff
Bollinger width17.18%
%B0.35
Donchian pos47.55%
Donchian high369.00
Donchian low297.02
AVWAP (52w high)340.83
vs AVWAP high-2.81%
AVWAP (52w low)259.88
vs AVWAP low+27.46%
OBV trendDown
Chaikin MF (20)-0.13
Today vs 20d0.64×
Avg vol (14d)742.91K
Avg vol (20d)650.92K
Avg $ vol (20d)217.86M
Market cap9.8B
RS 3m (vs SPY)+4.33%
RS 6m (vs SPY)+7.86%
RS line new highNo
Trend template7/8
Technical rank61.2
1 week+5.97%
1 month-9.45%
3 months+8.35%
6 months+21.45%
1 year+143.38%
YTD+34.16%
P/E47.87
P/B7.21
P/S25.20
P/FCF51.90
EPS6.84
Div yield—
ROE15.07%
ROA13.65%
Debt/Eq0.00
Current8.32
EV/EBITDA56.73
Gross margin—
Net margin52.64%
Rev growth33.94%
EPS growth129.74%
Price target403.20
Target upside21.72%
Analyst ratingBuy
Institutional110.08%
Ent. value9.38B
Revenue119.22M
Net income54.77M
Gross profit—
Free cash flow188.91M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out29.48M
Employees295
ListedWed, Sep 20, 2017
Free float23.93M
Float %81.3%
Short interest3.5M
Days to cover11.4d
Short volume78.3%
Squeeze score74 / 100
Next earnings—
EPS forecast—
Last EPS vs est$1.79 vs $1.70
Last surprise+5.3% beat
Setup gradeC
Conviction58 / 100
Pattern quality—
Tech rank61.2 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance382.33
Support311.01
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 47 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

  1. Broke out
    Jun 1
    1 scan
  2. Setting up
    Jun 9 – Jul 13
    5 scans

Congress activity

Disclosed STOCK Act trades in KRYS

All disclosures →
No recent disclosed trades by Congress in KRYS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in KRYS · 9 sells

InsiderSideShares
Krishnan Suma
President, R&D · Common Stock · 2026-06-04
Sell12.73K
Krishnan Krish S
President and CEO · Common Stock · 2026-06-04
Sell964
Krishnan Krish S
President and CEO · Common Stock · 2026-06-04
Other—
Krishnan Krish S
President and CEO · Common Stock · 2026-06-04
Sell589
Krishnan Krish S
President and CEO · Common Stock · 2026-06-04
Sell320
Krishnan Suma
President, R&D · Common Stock · 2026-06-04
Sell400
Krishnan Suma
President, R&D · Common Stock · 2026-06-04
Sell480
Krishnan Krish S
President and CEO · Common Stock · 2026-06-04
Sell2.65K
Krishnan Krish S
President and CEO · Common Stock · 2026-06-04
Sell2.78K
Krishnan Suma
President, R&D · Common Stock · 2026-06-04
Sell3.8K

SEC filings

EDGAR filings in KRYS · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.